• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Syra Health Partners with Indiana Department of Health

Share:

January 23, 2024

Indiana-based healthcare technology company Syra Health has signed a one-year, $480,000 contract with the Indiana Department of Health to assess the impact of existing public health risks on public health infrastructure and behavioral health in the state. Syra Health will use its population health tools and analytics to identify risks, assist in resource allocation, and create a health network for Indiana residents. The contract includes the potential for a one-year extension based on the success of the collaboration.

Syra Health, a healthcare technology company that provides tools to analyze population health, announced it signed a one-year $480,000 contract to assess how existing risks to public health in Indiana impact public health infrastructure and behavioral health.

Syra is an Indiana-based company that provides population health tools, including health equity analytical solutions and epidemiology-focused offerings.

The company also offers analytics about identifying and addressing social determinants of health using data from various resources that monitor and track health outcomes.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Under the agreement with the Indiana Department of Health, the company will help identify risks that may exist to public health and the state’s healthcare system.

It will also assist the state and its partners in finding where the parties should focus their resources to create a health network for Indiana residents.

Should the collaboration be successful during its first year, the contract includes the potential for a one-year extension.

“As states wrestle with ongoing threats to public health such as mental and behavioral health, we anticipate additional calls for similar work,” Dr. Deepika Vuppalanchi, CEO of Syra Health, said in a statement.

THE LARGER TREND

Syra Health became a publicly traded company in September, opening on the NASDAQ at a stock price of $3.00 per share. Its stock closed today at $0.96.

In November, Syra announced it signed a five-year $275,000 contract to examine the City of San Antonio’s implementation of its Racial and Ethnic Approaches to Community Health (REACH) project.

That same month, the company secured a two-year contract with Minnesota’s Department of Human Services, valued at nearly $215,000, to evaluate the needs of Hennepin County’s Hispanic and Latino communities and to support those needs by implementing Culturally and Linguistically Appropriate Services (CLAS) standards.

Source: Bio Space

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • As Telehealth Surges, Are Seniors Being Left Behind?As Telehealth Surges, Are Seniors Being Left Behind?
  • New Future Market Insights Report Explores Impact of Covid-19 Outbreak on Apoptosis Testing MarketNew Future Market Insights Report Explores Impact of Covid-19 Outbreak on Apoptosis Testing Market
  • Incannex to Acquire Apirx Pharmaceuticals USA, LLCIncannex to Acquire Apirx Pharmaceuticals USA, LLC
  • Capital Rx Wins Top Award at Accenture HealthTech Innovation ChallengeCapital Rx Wins Top Award at Accenture HealthTech Innovation Challenge
  • Curaleaf to Buy Leading West Coast Cannabis Oils Brand for $949 Million in StockCuraleaf to Buy Leading West Coast Cannabis Oils Brand for $949 Million in Stock
  • Octave Bioscience Announces Strategic Investment from the Merck Global Health Innovation Fund to Transform Disease Measurement and Care for Patients with Neurodegenerative DiseasesOctave Bioscience Announces Strategic Investment from the Merck Global Health Innovation Fund to Transform Disease Measurement and Care for Patients with Neurodegenerative Diseases
  • Agiliti Acquires Northfield Medical, Inc.Agiliti Acquires Northfield Medical, Inc.
  • Nodal, A Platform Connecting Intended Parents with Surrogates, Raises $4.7MNodal, A Platform Connecting Intended Parents with Surrogates, Raises $4.7M

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications